Fulfillment Operations for Peptide Companies — Why Most Founders Get This Wrong First

Most peptide founders are strong on marketing and weak on fulfillment — and it shows up first as a few delayed orders, then as a support queue that never clears, then as refund requests that erode margin and trust simultaneously. Fulfillment is unglamorous, but it determines whether a brand with good marketing actually survives contact with real order volume.

Single-Supplier Dependence Is the Root Cause

The most common failure pattern is relying on one supplier for the entire catalog. When that supplier has a delay, a stock-out, or a quality issue, every order in the pipeline is affected simultaneously. There is no buffer and no alternative path to fulfillment.

Building Supplier Redundancy

The fix is qualifying at least one backup supplier per major product category before you need them — not after a delay has already happened. This means going through the same documentation and verification process for a second source as you did for the first, so it's ready to activate without a scramble.

Inventory Forecasting Over Reactive Ordering

Reordering only when stock hits zero guarantees stockouts, because lead times are rarely instant. Forecasting based on recent sell-through velocity — and reordering at a threshold that accounts for lead time — keeps inventory ahead of demand rather than chasing it.

Writing the SOP Before You Need It

Every fulfillment step — receiving inventory, picking, packing, labeling, handoff to carrier — should be documented as a repeatable process, not held in the founder's head. This is what makes delegation possible later and what keeps fulfillment consistent when order volume spikes.